140 related articles for article (PubMed ID: 3079163)
1. Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival.
Claesson K; Larsson P; Holmdahl R; Klareskog L; Forsum U; Tufveson G
Transplant Proc; 1987 Feb; 19(1 Pt 1):615-6. PubMed ID: 3079163
[No Abstract] [Full Text] [Related]
2. Intrathymic tolerance induction is based on suppressor cells.
Kampinga J; Klatter F; Bartels H; Pater J; Nieuwenhuis P; Roser B; Groen H
Transplant Proc; 1994 Apr; 26(2):725-6. PubMed ID: 8171626
[No Abstract] [Full Text] [Related]
3. Effect of ex vivo perfusion with anti-Ia monoclonal antibodies on rat cardiac allograft survival.
Sone Y; Sakagami K; Orita K
Transplant Proc; 1987 Feb; 19(1 Pt 1):599-604. PubMed ID: 3547831
[No Abstract] [Full Text] [Related]
4. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
Pearson TC; Hamano K; Morris PJ; Wood KJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
[No Abstract] [Full Text] [Related]
5. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
Oko A; Krzymański M; Deja A; Pawliczak E; Idasiak-Piechocka I
Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
[No Abstract] [Full Text] [Related]
6. Graft survival in a hamster-to-rat heart transplantation model after treatment with total lymphoid irradiation, cyclosporine A, and a monoclonal anti-T-cell antibody.
Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C
Transplant Proc; 1990 Jun; 22(3):1088. PubMed ID: 2349667
[No Abstract] [Full Text] [Related]
7. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
[TBL] [Abstract][Full Text] [Related]
8. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H
Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
[No Abstract] [Full Text] [Related]
9. The role of anti-class II HLA antibodies in heart transplantation.
Nikaein A; Alivizatos PA; Monahan K; Stone MJ
Transplantation; 1995 Feb; 59(3):439-42. PubMed ID: 7871580
[No Abstract] [Full Text] [Related]
10. Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice.
Mottram PL; Smyth M; Pietersz GA; Clunie GJ; McKenzie IF
Transplant Proc; 1989 Feb; 21(1 Pt 1):1020-1. PubMed ID: 2650063
[No Abstract] [Full Text] [Related]
11. Elimination of OX8+ cells prolongs cardiac but not pancreatic allograft survival across minor (non-MHC) histocompatibility barriers.
Roza AM; Johnson CP; Adams MB; Naji A
Transplant Proc; 1990 Apr; 22(2):747-8. PubMed ID: 2327028
[No Abstract] [Full Text] [Related]
12. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
Kirkman RL; Barrett LV; Koltun WA; Diamantstein T
Transplant Proc; 1987 Feb; 19(1 Pt 1):618-9. PubMed ID: 3274828
[No Abstract] [Full Text] [Related]
13. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
[No Abstract] [Full Text] [Related]
14. Dose-dependent effect of intrathymically injected 3-mol/L KCl-extracted histocompatibility antigens to prolong heart allograft survival in rats.
Hamashima T; Stepkowski SM; Kahan BD
Transplant Proc; 1995 Feb; 27(1):134-5. PubMed ID: 7878904
[No Abstract] [Full Text] [Related]
15. TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survival.
Heidecke CD; Hancock WW; Jakobs F; Westerholt S; Sewzcik T; Deusch K; Zantl N; Kurrle R; Kupiec-Weglinski J
Transplant Proc; 1993 Feb; 25(1 Pt 1):540-2. PubMed ID: 8438405
[No Abstract] [Full Text] [Related]
16. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H
Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
[No Abstract] [Full Text] [Related]
17. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR
Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538
[No Abstract] [Full Text] [Related]
18. The effect of reduction of class II antigens on the survival of pancreatic allografts.
Spillenaar-Bilgen EJ; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
Transplant Proc; 1989 Feb; 21(1 Pt 1):515-6. PubMed ID: 2495619
[No Abstract] [Full Text] [Related]
19. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
[No Abstract] [Full Text] [Related]
20. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
